跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,279 条关于
“Kanghong Pharmaceutical”
全部
13,279
临床试验
555
药物
1,677
机构
2,165
资讯
8,882
7个月前
World's First Dual-Payload ADC KH815 Enters Clinical Trials with BioDlink Manufacturing Support
4个月前
KH607 Meets Primary Endpoint in Phase 2b Trial for Major Depressive Disorder
3个月前
Hengrui's Heng Yi Wins NMPA Approval as China's First Water-Free Cyclosporine Ophthalmic Solution for Dry Eye Disease
去年
Dual-Payload ADCs Enter Clinical Testing as Innovent and Chengdu Kanghong Pioneer Next-Generation Cancer Therapeutics
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Pharmaceutical R&D Highlights: Key Clinical Updates from November 2024
去年
Lilly Expands Obesity Treatment Pipeline Through KeyBioscience Collaboration
去年
FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa
去年
SPIMA Therapeutics Launches with Focus on Peptide-Based Immunotherapies for Unmet Needs
去年
RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development
第 1 页,共 889 页
上一页
下一页